Oleolive, Inc.
Shreveport, LA
- UEI
- DSBCG7NS87J3
- CAGE
- 81W82
- Primary NAICS
- 325411 Medicinal and Botanical Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 2031 Kings Hwy #236, Shreveport, LA 71103, USA
- Website
- oleo.live
- Founded
- 2017
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Repurposing pyrvinium as an inhalation therapy for idiopathic pulmonary fibrosis - summary idiopathic pulmonary fibrosis… | National Heart Lung and Blood Institute | $625,336 | |
| Chemosensitization of glioblastoma by propentofylline - summary glioblastoma (GBM) is the most common primary tumor of… | National Cancer Institute | $799,996 | |
| Covid-19 DIB agile-PRP lyophilized platelet rich blood product | Air Force Research Laboratory | $499,965 | |
| Oleocanthal functional food products for breast cancer recurrence control | National Cancer Institute | $549,034 | |
| Evaluation of a dual ppar agonist for treatment of alzheimer's disease - summary alzheimer's disease (ad) is the sixth… | National Institute on Aging | $8,631,056 |
About Oleolive, Inc.
Oleolive, Inc. is a preclinical biotechnology company developing novel therapies and products related to oleocanthal, an anti-inflammatory compound from olive oil. Through federal contracts and grants, Oleolive conducts research to commercialize oleocanthal and apply it to supplements, therapeutics, and other novel uses.
Oleolive has received two prime federal contracts from the Department of the Air Force to develop innovative defense-related dual-purpose technologies and a lyophilized platelet rich blood product for COVID-19 response. Both contracts were set aside for small businesses.
Through federal grants, Oleolive conducts research related to cancer and Alzheimer's disease treatment. Grants from the National Cancer Institute support development of oleocanthal functional food products to control breast cancer recurrence and methods to sensitize glioblastoma tumors to temozolomide chemotherapy. Grants from the National Institute on Aging support evaluation of novel PPAR delta/gamma and PPAR-gamma agonists to treat Alzheimer's disease by reducing amyloid accumulation, tau phosphorylation, neuroinflammation and neuronal damage in mouse models. Research outcomes could lead to clinical trials for these indications.
Quick answers
What is Oleolive, Inc.'s UEI?
Oleolive, Inc.'s Unique Entity ID (UEI) in SAM.gov is DSBCG7NS87J3.
What is Oleolive, Inc.'s CAGE code?
Oleolive, Inc.'s CAGE code is 81W82.
What is Oleolive, Inc.'s primary NAICS code?
Oleolive, Inc.'s primary NAICS code is 325411 (Medicinal and Botanical Manufacturing).
Where is Oleolive, Inc. located?
Oleolive, Inc.'s physical address in SAM.gov is 2031 Kings Hwy #236, Shreveport, LA 71103, USA.
Is Oleolive, Inc. registered in SAM.gov?
Yes. Oleolive, Inc.'s SAM.gov registration is active through July 29, 2027.
What is Oleolive, Inc.'s most recent federal award?
Oleolive, Inc.'s most recent federal grant award is Repurposing pyrvinium as an inhalation therapy for idiopathic pulmonary fibrosis - summary idiopathic pulmonary fibrosis… (R41HL180136), from National Heart Lung and Blood Institute, on September 20, 2025.
On GovTribe
See Oleolive, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors